NCT02807402View on ClinicalTrials.gov

Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, + Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in Romania

CompletedOBSERVATIONAL
Enrollment

522

Participants

Timeline

Start Date

July 14, 2016

Primary Completion Date

August 4, 2017

Study Completion Date

August 4, 2017

Conditions
Chronic Hepatitis C
Sponsors

Lead Sponsor

AbbVie
All Listed Sponsors
collaborator

IST GmbH, Germany

INDUSTRY

lead

AbbVie

INDUSTRY